Home Archives - BioBridge Global

BBG Advanced Therapies and CELLforCURE Partner to Provide Transatlantic Manufacturing Solutions for Advanced Therapy Medicinal Products (ATMPs)

October 7, 2025

Collaboration establishes a transatlantic connection enabling U.S. companies to leverage CELLforCURE’s manufacturing capabilities in Europe, while European companies can benefit from BBG Advanced Therapies’ production

Blueprint For Breakthroughs: Adrienne Mendoza Rethinks How Advanced Therapies Can Be Scaled.

CGT Wake Up Call To Rethink How Advanced Therapies Scale

August 26, 2025

Blueprint for Breakthroughs is a LinkedIn newsletter published by Adrienne B. Mendoza, MHA, SVP BioBridge Global and Chief Operating Officer (COO), BBG Advanced Therapies Originally

The blood bank and the future of cell & gene therapies. Blueprint for Breakthroughs.

The Blood Bank and the Future of Advanced Therapies

August 12, 2025

Blueprint for Breakthroughs is a LinkedIn newsletter published by Adrienne B. Mendoza, MHA, SVP BioBridge Global and Chief Operating Officer (COO), BBG Advanced Therapies Originally

Adrienne B Mendoza, Blueprint for breakthroughs, Potency Testing for advanced therapies

How Potency Testing Can Delay Advanced Therapies

August 12, 2025

Blueprint for Breakthroughs is a LinkedIn newsletter published by Adrienne B. Mendoza, MHA, SVP BioBridge Global and Chief Operating Officer (COO), BBG Advanced Therapies Originally

Potency Assays: The Key to Scalable Advanced Therapies

July 29, 2025

Blueprint for Breakthroughs is a LinkedIn newsletter published by Adrienne B. Mendoza, MHA, SVP BioBridge Global and Chief Operating Officer (COO), BBG Advanced Therapies Originally

Adrienne Mendoza discusses how rethink the cleanroom can lead to breakthroughs while maintaining GMP quality

Rethinking Cleanroom Dependence in Advanced Therapies to Deliver as Personalized, Scalable, and Accessible

June 24, 2025

Blueprint for Breakthroughs is a LinkedIn newsletter published by Adrienne B. Mendoza, MHA, SVP BioBridge Global and Chief Operating Officer (COO), BBG Advanced Therapies Originally

Guide to Decoupling Leukapheresis from Clinical Sites to Scale Out Access Blueprint for Breakthroughs

Breaking the Bottleneck to Clear Access to Cell and Gene Therapy

May 20, 2025

Blueprint for Breakthroughs is a LinkedIn newsletter published by Adrienne B. Mendoza, MHA, SVP BioBridge Global and Chief Operating Officer (COO), BBG Advanced Therapies Originally

BBG Advanced Therapies launched its first-in-the-world mobile leukapheresis center supporting cell and gene therapies

BBG Advanced Therapies Launches First Mobile Leukapheresis Center

May 6, 2025

New mobile leukapheresis center will help bring lifesaving treatments to a wider patient base SAN ANTONIO, Texas – BBG Advanced Therapies, a subsidiary of San

The Road Behind the First Mobile Leukapheresis Center

May 6, 2025

Blueprint for Breakthroughs is a LinkedIn newsletter published by Adrienne B. Mendoza, MHA, SVP BioBridge Global and Chief Operating Officer (COO), BBG Advanced Therapies Originally

Reimagining Access to Advanced Cell Therapies

April 22, 2025

Blueprint for Breakthroughs is a LinkedIn newsletter published by Adrienne B. Mendoza, MHA, SVP BioBridge Global and Chief Operating Officer (COO), BBG Advanced Therapies Originally

How to build resilience for advanced therapies with supply chain and resource planning

Supply Chain Builds Resilience for Advanced Therapies

April 4, 2025

Originally published as “How To Build Resilience for Advanced Therapies with Supply Chain and Resource Planning”on LinkedIn on March 25, 2025 Blueprint for Breakthroughs is

How electronic batch records accelerate advanced therapy access Blueprint for Breakthroughs

Setting Your Biotech Up for Success: How Electronic Batch Records Accelerate Advanced Therapy Access

March 19, 2025

Blueprint for Breakthroughs is a LinkedIn newsletter published by Adrienne B. Mendoza, MHA, SVP BioBridge Global and Chief Operating Officer (COO), BBG Advanced Therapies Originally

News